BIB ProShares Ultra Nasdaq Biotechnology
123.98
-1.31 (-1.05%)
Cotización a fecha de Aug 26, 2026 20:00 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Cierre anterior | 125.29 | Rango diario | 123.47 – 124.51 |
| Rango de 52 semanas | 54.85 – 126.40 | Volumen | 3.90K |
| Volumen prom. | 11.43K | AUM | $107.7M (Aug 27, 2026) |
| Ratio de gastos | 1.19% | Rendimiento (TTM) | 0.26% |
| NAV | 123.82 | Prima/Descuento | +0.13% indicativo |
| Inicio | Apr 07, 2010 | Posiciones | 274 |
| Emisor | ProShares | Bolsa | NASDAQ |
| Categoría | Biotech | Índice replicado | No indicado en los datos de origen |
| CUSIP | 74347R214 | ISIN | US74347R2141 |
| Gestión | Pasivo / seguimiento de índice (según descripción del emisor) | ||
Sobre este ETF
ProShares Trust - ProShares Ultra Nasdaq Biotechnology is an exchange traded fund launched and managed by ProShare Advisors LLC. It invests in public equity markets of the United States. It invests through derivatives in stocks of companies operating across health care, pharmaceuticals, biotechnology, drugs manufacturer, diagnostic development and life sciences sectors. It uses derivatives such as swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track 2x the daily performance of the Nasdaq Biotechnology Index, by using full replication technique. ProShares Trust - ProShares Ultra Nasdaq Biotechnology was formed on April 7, 2010 and is domiciled in the United States.
Descripción proporcionada por el proveedor de datos del fondo · perfil a fecha de Aug 27, 2026.
Gráfico de precios
Precios de cierre diarios (rentabilidad por precio, no rentabilidad total). Las líneas de comparación se normalizan al cambio porcentual desde el inicio del período. Fuente: Financial Modeling Prep.
Rentabilidad
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Inicio* | |
|---|---|---|---|---|---|---|---|---|---|
| Rentabilidad por precio | +25.74% | +49.27% | +41.00% | +55.40% | +121.91% | +33.77% | +3.51% | +10.11% | +18.67% |
| Rentabilidad total | +25.74% | +49.27% | +41.01% | +55.42% | +123.03% | +34.97% | +4.08% | +10.41% | +18.87% |
* Anualizado. La rentabilidad total utiliza la serie de precios ajustada por dividendos (distribuciones reinvertidas); la rentabilidad por precio utiliza cierres sin ajustar. Rentabilidad a Aug 26, 2026. La rentabilidad pasada no garantiza resultados futuros.
Comisiones
| Expense ratio neto | 1.19% | Coste anual de una inversión de 10.000 $ | $119.00 |
Cálculo meramente ilustrativo: expense ratio × 10.000 $. No incluye costes de negociación, diferenciales compra/venta, impuestos ni variaciones en el valor de la inversión. Los detalles de gastos brutos y netos, así como cualquier exención de comisiones, figuran en el folleto.
Posiciones
Posiciones a fecha de Aug 22, 2026 — fecha de reporte de cartera del proveedor de datos; las posiciones no son en tiempo real. 259 filas en la base de datos.
| # | Posición | Ticker | Peso | Acciones | Valor de mercado |
|---|---|---|---|---|---|
| 1 | Net Other Assets (Liabilities) | — | 43.28% | 44.91M | $44.9M |
| 2 | PROSHARES GENIUS MNY MKT ETF | IQMM | 4.82% | 50.00K | $5.0M |
| 3 | AMGEN INC | AMGN | 4.50% | 10.63K | $4.7M |
| 4 | VERTEX PHARMACEUTICALS INC | VRTX | 4.23% | 8.01K | $4.4M |
| 5 | GILEAD SCIENCES INC | GILD | 3.75% | 26.65K | $3.9M |
| 6 | REGENERON PHARMACEUTICALS | REGN | 2.83% | 3.52K | $2.9M |
| 7 | MODERNA INC | MRNA | 1.90% | 13.56K | $2.0M |
| 8 | REVOLUTION MEDICINES INC | RVMD | 1.47% | 7.26K | $1.5M |
| 9 | ILLUMINA INC | ILMN | 1.09% | 5.17K | $1.1M |
| 10 | BIOGEN INC | BIIB | 1.05% | 5.04K | $1.1M |
| 11 | ALNYLAM PHARMACEUTICALS INC | ALNY | 1.04% | 4.56K | $1.1M |
| 12 | ARGENX SE - ADR | ARGX | 0.95% | 944 | $981.6K |
| 13 | INSMED INC | INSM | 0.90% | 7.41K | $931.6K |
| 14 | ROYALTY PHARMA PLC- CL A | RPRX | 0.90% | 15.15K | $929.0K |
| 15 | ROIVANT SCIENCES LTD | ROIV | 0.86% | 24.57K | $892.1K |
| 16 | INCYTE CORP | INCY | 0.84% | 6.83K | $872.6K |
| 17 | GUARDANT HEALTH INC | GH | 0.75% | 4.53K | $773.6K |
| 18 | UNITED THERAPEUTICS CORP | UTHR | 0.72% | 1.45K | $744.5K |
| 19 | VIATRIS INC | VTRS | 0.63% | 39.79K | $649.4K |
| 20 | MEDPACE HOLDINGS INC | MEDP | 0.58% | 974 | $604.6K |
| 21 | BRIDGEBIO PHARMA INC | BBIO | 0.53% | 6.69K | $545.2K |
| 22 | JAZZ PHARMACEUTICALS PLC | JAZZ | 0.53% | 2.14K | $545.2K |
| 23 | ASCENDIS PHARMA A/S | ASND | 0.51% | 2.11K | $533.4K |
| 24 | NEUROCRINE BIOSCIENCES INC | NBIX | 0.51% | 3.44K | $524.4K |
| 25 | EXELIXIS INC | EXEL | 0.45% | 8.59K | $464.5K |
| 26 | BIONTECH SE-ADR | BNTX | 0.45% | 3.97K | $463.0K |
| 27 | BIOMARIN PHARMACEUTICAL INC | BMRN | 0.42% | 6.60K | $440.4K |
| 28 | HALOZYME THERAPEUTICS INC | HALO | 0.42% | 4.05K | $438.3K |
| 29 | TEMPUS AI INC-CL A | TEM | 0.42% | 5.96K | $433.3K |
| 30 | BEONE MEDICINES LTD-ADR | ONC | 0.41% | 1.13K | $421.7K |
| 31 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 0.40% | 4.81K | $419.0K |
| 32 | MADRIGAL PHARMACEUTICALS INC | MDGL | 0.39% | 789 | $407.7K |
| 33 | AXSOME THERAPEUTICS INC | AXSM | 0.35% | 1.76K | $364.8K |
| 34 | SANOFI-ADR | SNY | 0.35% | 7.95K | $364.5K |
| 35 | PRAXIS PRECISION MEDICINES I | PRAX | 0.35% | 955 | $359.0K |
| 36 | CYTOKINETICS INC | CYTK | 0.34% | 4.63K | $356.0K |
| 37 | KRYSTAL BIOTECH INC | KRYS | 0.34% | 1.01K | $350.0K |
| 38 | SUMMIT THERAPEUTICS INC | SMMT | 0.34% | 26.52K | $349.0K |
| 39 | PROTAGONIST THERAPEUTICS INC | PTGX | 0.33% | 2.20K | $339.2K |
| 40 | IONIS PHARMACEUTICALS INC | IONS | 0.32% | 5.64K | $337.2K |
| 41 | KYMERA THERAPEUTICS INC | KYMR | 0.32% | 2.81K | $336.9K |
| 42 | SPYRE THERAPEUTICS INC | SYRE | 0.30% | 2.97K | $316.3K |
| 43 | IMMUNOVANT INC | IMVT | 0.30% | 7.01K | $311.3K |
| 44 | TWIST BIOSCIENCE CORP | TWST | 0.30% | 2.13K | $309.7K |
| 45 | VAXCYTE INC | PCVX | 0.30% | 4.93K | $308.8K |
| 46 | CRINETICS PHARMACEUTICALS IN | CRNX | 0.29% | 3.60K | $305.2K |
| 47 | APOGEE THERAPEUTICS INC | APGE | 0.27% | 2.11K | $284.7K |
| 48 | IMMUNITYBIO INC | IBRX | 0.27% | 35.79K | $278.8K |
| 49 | ALKERMES PLC | ALKS | 0.27% | 5.69K | $275.1K |
| 50 | 10X GENOMICS INC-CLASS A | TXG | 0.25% | 4.00K | $260.7K |
| 51 | RHYTHM PHARMACEUTICALS INC | RYTM | 0.25% | 2.34K | $257.7K |
| 52 | CARIS LIFE SCIENCES INC | CAI | 0.24% | 9.66K | $253.7K |
| 53 | CG ONCOLOGY INC | CGON | 0.23% | 3.01K | $240.5K |
| 54 | SCHOLAR ROCK HOLDING CORP | SRRK | 0.22% | 4.09K | $231.3K |
| 55 | ABIVAX SA-ADR | ABVX | 0.22% | 1.98K | $227.7K |
| 56 | ORUKA THERAPEUTICS INC | ORKA | 0.21% | 2.06K | $222.3K |
| 57 | COGENT BIOSCIENCES INC | COGT | 0.21% | 5.84K | $214.5K |
| 58 | TRAVERE THERAPEUTICS INC | TVTX | 0.20% | 3.18K | $208.8K |
| 59 | MIRUM PHARMACEUTICALS INC | MIRM | 0.19% | 2.08K | $200.7K |
| 60 | XENON PHARMACEUTICALS INC | XENE | 0.19% | 3.30K | $200.5K |
| 61 | PTC THERAPEUTICS INC | PTCT | 0.19% | 2.83K | $197.7K |
| 62 | LIGAND PHARMACEUTICALS | LGND | 0.19% | 686 | $196.4K |
| 63 | CRISPR THERAPEUTICS AG | CRSP | 0.19% | 3.30K | $196.2K |
| 64 | AMNEAL PHARMACEUTICALS INC | AMRX | 0.19% | 10.90K | $195.2K |
| 65 | ERASCA INC | ERAS | 0.18% | 10.63K | $187.4K |
| 66 | ACADIA PHARMACEUTICALS INC | ACAD | 0.17% | 5.85K | $172.5K |
| 67 | DEFINIUM THERAPEUTICS INC | DFTX | 0.16% | 3.72K | $167.2K |
| 68 | EDGEWISE THERAPEUTICS INC | EWTX | 0.16% | 3.67K | $162.4K |
| 69 | INDIVIOR PHARMACEUTICALS INC | INDV | 0.15% | 4.17K | $153.6K |
| 70 | DYNE THERAPEUTICS INC | DYN | 0.14% | 5.65K | $147.4K |
| 71 | AMYLYX PHARMACEUTICALS INC | AMLX | 0.14% | 3.80K | $146.9K |
| 72 | RELAY THERAPEUTICS INC | RLAY | 0.14% | 7.33K | $142.5K |
| 73 | ADAPTIVE BIOTECHNOLOGIES | ADPT | 0.14% | 5.47K | $142.1K |
| 74 | DENALI THERAPEUTICS INC | DNLI | 0.13% | 5.42K | $135.1K |
| 75 | STRUCTURE THERAPEUTICS INC | GPCR | 0.13% | 2.67K | $130.9K |
| 76 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 0.12% | 15.26K | $126.5K |
| 77 | KINIKSA PHARMACEUTICALS INTE | KNSA | 0.12% | 1.58K | $125.1K |
| 78 | ENLIVEN THERAPEUTICS INC | ELVN | 0.12% | 2.08K | $124.5K |
| 79 | IDEAYA BIOSCIENCES INC | IDYA | 0.11% | 3.00K | $119.0K |
| 80 | ABCELLERA BIOLOGICS INC | ABCL | 0.11% | 10.43K | $118.1K |
| 81 | TANGO THERAPEUTICS INC | TNGX | 0.11% | 4.94K | $118.0K |
| 82 | GRAIL INC | GRAL | 0.11% | 1.47K | $116.7K |
| 83 | VERACYTE INC | VCYT | 0.11% | 2.73K | $115.5K |
| 84 | NEWAMSTERDAM PHARMA CO NV | — | 0.11% | 3.99K | $111.3K |
| 85 | MBX BIOSCIENCES INC | MBX | 0.10% | 1.62K | $107.7K |
| 86 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 0.10% | 4.27K | $107.2K |
| 87 | TARSUS PHARMACEUTICALS INC | TARS | 0.10% | 1.47K | $106.9K |
| 88 | UNIQURE NV | QURE | 0.10% | 2.16K | $104.5K |
| 89 | BEAM THERAPEUTICS INC | BEAM | 0.10% | 3.51K | $104.4K |
| 90 | DISC MEDICINE INC | IRON | 0.10% | 1.31K | $104.2K |
| 91 | ALUMIS INC | ALMS | 0.10% | 4.22K | $102.0K |
| 92 | NURIX THERAPEUTICS INC | NRIX | 0.09% | 3.53K | $94.3K |
| 93 | ATAIBECKLEY INC | ATAI | 0.09% | 12.58K | $92.8K |
| 94 | SUPERNUS PHARMACEUTICALS INC | SUPN | 0.09% | 1.98K | $91.0K |
| 95 | PRECIGEN INC | PGEN | 0.08% | 12.18K | $87.7K |
| 96 | TREVI THERAPEUTICS INC | TRVI | 0.08% | 4.85K | $87.2K |
| 97 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 0.08% | 3.36K | $86.9K |
| 98 | GENMAB A/S -SP ADR | GMAB | 0.08% | 2.59K | $86.7K |
| 99 | PHARVARIS NV | PHVS | 0.08% | 2.39K | $86.5K |
| 100 | BIOCRYST PHARMACEUTICALS INC | BCRX | 0.08% | 8.68K | $82.9K |
| 101 | OCULAR THERAPEUTIX INC | OCUL | 0.08% | 7.48K | $82.9K |
| 102 | KODIAK SCIENCES INC | KOD | 0.08% | 2.14K | $81.9K |
| 103 | VERA THERAPEUTICS INC | VERA | 0.08% | 2.45K | $79.1K |
| 104 | RAPPORT THERAPEUTICS INC | RAPP | 0.08% | 1.64K | $78.9K |
| 105 | UROGEN PHARMA LTD | URGN | 0.08% | 1.67K | $78.0K |
| 106 | ADMA BIOLOGICS INC | ADMA | 0.08% | 7.92K | $77.9K |
| 107 | HARMONY BIOSCIENCES HOLDINGS | HRMY | 0.07% | 1.98K | $75.5K |
| 108 | VERICEL CORP | VCEL | 0.07% | 1.74K | $74.3K |
| 109 | AURINIA PHARMACEUTICALS INC | AUPH | 0.07% | 4.39K | $73.0K |
| 110 | MINERALYS THERAPEUTICS INC | MLYS | 0.07% | 2.82K | $72.3K |
| 111 | ZYMEWORKS INC | ZYME | 0.07% | 2.49K | $71.5K |
| 112 | XENCOR INC | XNCR | 0.07% | 2.53K | $70.4K |
| 113 | ZENAS BIOPHARMA INC | ZBIO | 0.07% | 2.16K | $69.7K |
| 114 | STOKE THERAPEUTICS INC | STOK | 0.07% | 2.13K | $68.7K |
| 115 | SAREPTA THERAPEUTICS INC | SRPT | 0.07% | 3.61K | $67.8K |
| 116 | NOVOCURE LTD | NVCR | 0.07% | 3.96K | $67.7K |
| 117 | AGIOS PHARMACEUTICALS INC | AGIO | 0.06% | 2.03K | $67.2K |
| 118 | GH RESEARCH PLC | GHRS | 0.06% | 2.34K | $66.2K |
| 119 | PERSONALIS INC | PSNL | 0.06% | 3.58K | $65.7K |
| 120 | LEGEND BIOTECH CORP-ADR | LEGN | 0.06% | 2.88K | $62.9K |
| 121 | RECURSION PHARMACEUTICALS-A | RXRX | 0.06% | 17.93K | $62.7K |
| 122 | SEPTERNA INC | SEPN | 0.06% | 1.54K | $61.5K |
| 123 | INTELLIA THERAPEUTICS INC | NTLA | 0.06% | 4.77K | $61.2K |
| 124 | COMPASS PATHWAYS PLC | CMPS | 0.06% | 4.55K | $60.7K |
| 125 | TAYSHA GENE THERAPIES INC | TSHA | 0.06% | 9.82K | $59.8K |
| 126 | SYNDAX PHARMACEUTICALS INC | SNDX | 0.06% | 3.03K | $59.5K |
| 127 | FORTREA HOLDINGS INC | FTRE | 0.06% | 3.23K | $59.4K |
| 128 | ETON PHARMACEUTICALS INC | ETON | 0.06% | 935 | $59.3K |
| 129 | ANI PHARMACEUTICALS INC | ANIP | 0.06% | 776 | $58.5K |
| 130 | ANAPTYSBIO INC | ANAB | 0.06% | 996 | $57.5K |
| 131 | VIR BIOTECHNOLOGY INC | VIR | 0.05% | 5.76K | $56.3K |
| 132 | IMMUNOCORE HOLDINGS PLC-ADR | IMCR | 0.05% | 1.52K | $56.1K |
| 133 | MAZE THERAPEUTICS INC | MAZE | 0.05% | 1.89K | $55.7K |
| 134 | BICARA THERAPEUTICS INC | BCAX | 0.05% | 2.25K | $53.7K |
| 135 | INNOVIVA INC | INVA | 0.05% | 2.52K | $53.1K |
| 136 | TYRA BIOSCIENCES INC | TYRA | 0.05% | 2.03K | $52.9K |
| 137 | HARROW INC | HROW | 0.05% | 1.27K | $52.0K |
| 138 | INHIBRX BIOSCIENCES INC | INBX | 0.05% | 499 | $51.7K |
| 139 | FIRST TRACKS BIOTHERAPEUTICS | TRAX | 0.05% | 1.19K | $51.4K |
| 140 | XERIS BIOPHARMA HOLDINGS INC | XERS | 0.05% | 5.90K | $51.3K |
| 141 | ABSCI CORP | ABSI | 0.05% | 5.33K | $50.9K |
| 142 | ORIC PHARMACEUTICALS INC | ORIC | 0.05% | 3.54K | $50.2K |
| 143 | NOVAVAX INC | NVAX | 0.05% | 5.62K | $50.2K |
| 144 | OMEROS CORP | OMER | 0.05% | 2.47K | $47.6K |
| 145 | ALVOTECH SA | ALVO | 0.05% | 10.66K | $47.2K |
| 146 | ARRIVENT BIOPHARMA INC | AVBP | 0.04% | 1.59K | $46.3K |
| 147 | CULLINAN THERAPEUTICS INC | CGEM | 0.04% | 2.10K | $45.5K |
| 148 | MEIRAGTX HOLDINGS PLC | MGTX | 0.04% | 3.16K | $45.4K |
| 149 | MANNKIND CORP | MNKD | 0.04% | 10.56K | $43.8K |
| 150 | MARAVAI LIFESCIENCES HLDGS-A | MRVI | 0.04% | 5.04K | $43.5K |
| 151 | VOR BIOPHARMA INC | VOR | 0.04% | 1.85K | $43.3K |
| 152 | REPLIMUNE GROUP INC | REPL | 0.04% | 2.82K | $41.7K |
| 153 | CORVUS PHARMACEUTICALS INC | CRVS | 0.04% | 2.88K | $41.6K |
| 154 | MONTE ROSA THERAPEUTICS INC | GLUE | 0.04% | 2.88K | $41.2K |
| 155 | SAVARA INC | SVRA | 0.04% | 7.00K | $39.1K |
| 156 | SANA BIOTECHNOLOGY INC | SANA | 0.04% | 9.51K | $37.2K |
| 157 | JANUX THERAPEUTICS INC | JANX | 0.03% | 2.08K | $36.2K |
| 158 | KURA ONCOLOGY INC | KURA | 0.03% | 3.04K | $36.1K |
| 159 | CASTLE BIOSCIENCES INC | CSTL | 0.03% | 1.04K | $35.5K |
| 160 | ARBUTUS BIOPHARMA CORP | ABUS | 0.03% | 6.75K | $35.2K |
| 161 | WAVE LIFE SCIENCES INC | WVE | 0.03% | 6.58K | $34.8K |
| 162 | GRIFOLS SA-ADR | GRFS | 0.03% | 4.17K | $33.4K |
| 163 | GERON CORP | GERN | 0.03% | 21.92K | $33.3K |
| 164 | PACIRA BIOSCIENCES INC | PCRX | 0.03% | 1.34K | $33.2K |
| 165 | CANDEL THERAPEUTICS INC | CADL | 0.03% | 2.50K | $32.9K |
| 166 | ARDELYX INC | ARDX | 0.03% | 8.44K | $32.8K |
| 167 | AMPHASTAR PHARMACEUTICALS IN | AMPH | 0.03% | 1.51K | $32.6K |
| 168 | OLEMA PHARMACEUTICALS INC | OLMA | 0.03% | 2.99K | $32.0K |
| 169 | DESIGN THERAPEUTICS INC | DSGN | 0.03% | 2.13K | $32.0K |
| 170 | SOLID BIOSCIENCES INC | SLDB | 0.03% | 3.36K | $31.3K |
| 171 | ACLARIS THERAPEUTICS INC | ACRS | 0.03% | 4.77K | $30.6K |
| 172 | MESOBLAST LTD- SPON ADR | MESO | 0.03% | 1.79K | $30.4K |
| 173 | COLLEGIUM PHARMACEUTICAL INC | COLL | 0.03% | 1.11K | $30.1K |
| 174 | THERAVANCE BIOPHARMA INC | TBPH | 0.03% | 1.76K | $30.0K |
| 175 | ZAI LAB LTD-ADR | ZLAB | 0.03% | 1.12K | $29.2K |
| 176 | RIGEL PHARMACEUTICALS INC | RIGL | 0.03% | 632 | $29.0K |
| 177 | ANNEXON INC | ANNX | 0.03% | 5.60K | $28.4K |
| 178 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 0.03% | 1.79K | $28.3K |
| 179 | AURA BIOSCIENCES INC | AURA | 0.03% | 3.53K | $27.6K |
| 180 | PHIBRO ANIMAL HEALTH CORP-A | PAHC | 0.03% | 719 | $26.1K |
| 181 | ALLOGENE THERAPEUTICS INC | ALLO | 0.02% | 11.79K | $24.6K |
| 182 | CYTOMX THERAPEUTICS INC | CTMX | 0.02% | 7.44K | $24.4K |
| 183 | TECTONIC THERAPEUTIC INC | TECX | 0.02% | 647 | $24.3K |
| 184 | PHATHOM PHARMACEUTICALS INC | PHAT | 0.02% | 2.73K | $24.2K |
| 185 | IRONWOOD PHARMACEUTICALS INC | IRWD | 0.02% | 5.62K | $24.1K |
| 186 | ZEVRA THERAPEUTICS INC | ZVRA | 0.02% | 2.02K | $24.0K |
| 187 | CORMEDIX INC | CRMD | 0.02% | 2.68K | $22.0K |
| 188 | OMNIAB INC | OABI | 0.02% | 4.96K | $21.5K |
| 189 | SAGIMET BIOSCIENCES INC-A | SGMT | 0.02% | 2.09K | $21.4K |
| 190 | SILENCE THERAPEUTICS PLC-ADR | SLN | 0.02% | 1.60K | $21.3K |
| 191 | NEUROGENE INC | NGNE | 0.02% | 542 | $20.9K |
| 192 | PRIME MEDICINE INC | PRME | 0.02% | 6.17K | $20.9K |
| 193 | ALTIMMUNE INC | ALT | 0.02% | 6.67K | $20.7K |
| 194 | ARVINAS INC | ARVN | 0.02% | 2.21K | $20.7K |
| 195 | AQUESTIVE THERAPEUTICS INC | AQST | 0.02% | 4.29K | $20.0K |
| 196 | CONTINEUM THERAPEUTICS INC-A | CTNM | 0.02% | 1.11K | $19.2K |
| 197 | REGENXBIO INC | RGNX | 0.02% | 1.77K | $18.9K |
| 198 | EVOLUS INC | EOLS | 0.02% | 2.25K | $18.9K |
| 199 | ARS PHARMACEUTICALS INC | SPRY | 0.02% | 3.39K | $18.7K |
| 200 | KYVERNA THERAPEUTICS INC | KYTX | 0.02% | 2.08K | $17.5K |
| 201 | CABALETTA BIO INC | CABA | 0.02% | 5.57K | $17.4K |
| 202 | PROTHENA CORP PLC | PRTA | 0.02% | 1.79K | $16.9K |
| 203 | AUTOLUS THERAPEUTICS PLC | AUTL | 0.02% | 6.85K | $16.5K |
| 204 | EDITAS MEDICINE INC | EDIT | 0.02% | 5.24K | $16.3K |
| 205 | KAMADA LTD | KMDA | 0.02% | 1.97K | $16.2K |
| 206 | PUMA BIOTECHNOLOGY INC | PBYI | 0.02% | 1.74K | $16.1K |
| 207 | EYEPOINT INC | EYPT | 0.01% | 2.87K | $15.2K |
| 208 | C4 THERAPEUTICS INC | CCCC | 0.01% | 3.78K | $15.1K |
| 209 | LARIMAR THERAPEUTICS INC | LRMR | 0.01% | 3.55K | $14.8K |
| 210 | ATEA PHARMACEUTICALS INC | AVIR | 0.01% | 2.73K | $14.8K |
| 211 | LAKEFRONT BIOTHERAPEUTIC-ADR | LKFT | 0.01% | 513 | $14.8K |
| 212 | BIOAGE LABS INC | BIOA | 0.01% | 1.52K | $14.4K |
| 213 | PACIFIC BIOSCIENCES OF CALIF | PACB | 0.01% | 10.65K | $14.4K |
| 214 | FOGHORN THERAPEUTICS INC | FHTX | 0.01% | 2.00K | $14.2K |
| 215 | ALPHA TEKNOVA INC | TKNO | 0.01% | 1.83K | $13.5K |
| 216 | ENANTA PHARMACEUTICALS INC | ENTA | 0.01% | 994 | $13.4K |
| 217 | ROCKET PHARMACEUTICALS INC | RCKT | 0.01% | 3.73K | $13.1K |
| 218 | LEXEO THERAPEUTICS INC | LXEO | 0.01% | 2.68K | $13.1K |
| 219 | ARCTURUS THERAPEUTICS HOLDIN | ARCT | 0.01% | 969 | $13.0K |
| 220 | UPSTREAM BIO INC | UPB | 0.01% | 1.86K | $13.0K |
| 221 | LYELL IMMUNOPHARMA INC | LYEL | 0.01% | 799 | $12.4K |
| 222 | IMMUNEERING CORP - CLASS A | IMRX | 0.01% | 2.21K | $11.7K |
| 223 | ORCHESTRA BIOMED HOLDINGS IN | OBIO | 0.01% | 2.05K | $11.0K |
| 224 | VANDA PHARMACEUTICALS INC | VNDA | 0.01% | 2.05K | $10.8K |
| 225 | NEUMORA THERAPEUTICS INC | NMRA | 0.01% | 6.33K | $10.3K |
| 226 | ANAVEX LIFE SCIENCES CORP | AVXL | 0.01% | 3.17K | $10.3K |
| 227 | AC IMMUNE SA | ACIU | 0.01% | 3.48K | $10.1K |
| 228 | INVIVYD INC | IVVD | 0.01% | 10.06K | $10.0K |
| 229 | ENTRADA THERAPEUTICS INC | TRDA | 0.01% | 1.32K | $10.0K |
| 230 | FULCRUM THERAPEUTICS INC | FULC | 0.01% | 2.28K | $8.7K |
| 231 | SIONNA THERAPEUTICS INC | SION | 0.01% | 1.54K | $8.1K |
| 232 | NOVABRIDGE BIOSCIENCES | NBP | 0.01% | 3.83K | $7.7K |
| 233 | COHERUS ONCOLOGY INC | CHRS | 0.01% | 5.27K | $7.5K |
| 234 | KEROS THERAPEUTICS INC | KROS | 0.01% | 676 | $7.5K |
| 235 | SIGA TECHNOLOGIES INC | SIGA | 0.01% | 2.45K | $7.4K |
| 236 | PEPGEN INC | PEPG | 0.01% | 2.37K | $7.4K |
| 237 | VOYAGER THERAPEUTICS INC | VYGR | 0.01% | 2.06K | $7.0K |
| 238 | BICYCLE THERAPEUTICS PLC-ADR | BCYC | 0.01% | 1.59K | $7.0K |
| 239 | PYXIS ONCOLOGY INC | PYXS | 0.01% | 2.16K | $6.7K |
| 240 | LIFECORE BIOMEDICAL INC | LFCR | 0.01% | 1.28K | $5.8K |
| 241 | JYONG BIOTECH LTD | MENS | 0.01% | 2.60K | $5.7K |
| 242 | QUANTUM-SI INC | QSI | 0.01% | 6.76K | $5.6K |
| 243 | CARIBOU BIOSCIENCES INC | CRBU | 0.01% | 3.39K | $5.6K |
| 244 | CODEXIS INC | CDXS | 0.01% | 3.11K | $5.2K |
| 245 | TENAYA THERAPEUTICS INC | TNYA | 0.00% | 7.41K | $5.2K |
| 246 | AARDVARK THERAPEUTICS INC | AARD | 0.00% | 747 | $5.1K |
| 247 | LENZ THERAPEUTICS INC | LENZ | 0.00% | 1.07K | $5.0K |
| 248 | HUMACYTE INC | HUMA | 0.00% | 7.59K | $4.9K |
| 249 | BLACK DIAMOND THERAPEUTICS I | BDTX | 0.00% | 1.96K | $4.3K |
| 250 | RANI THERAPEUTICS HOLDINGS-A | RANI | 0.00% | 3.84K | $3.4K |
| 251 | GOSSAMER BIO INC | GOSS | 0.00% | 8.02K | $1.2K |
| 252 | NASDAQ Biotechnology Index SWAP Citibank NA | — | 0.00% | 4.80K | $0.00 |
| 253 | NASDAQ Biotechnology Index SWAP Bank of America… | — | 0.00% | 5.72K | $0.00 |
| 254 | NASDAQ Biotechnology Index SWAP UBS AG | — | 0.00% | 629 | $0.00 |
| 255 | NASDAQ Biotechnology Index SWAP Societe Generale | — | 0.00% | 2.51K | $0.00 |
| 256 | THIRD HARMONIC BIO INC | THRD | 0.00% | 1.66K | $0.00 |
| 257 | CARTESIAN THERAPEUTICS-CVR | — | 0.00% | 9.79K | $0.00 |
| 258 | NASDAQ Biotechnology Index SWAP Goldman Sachs… | — | 0.00% | 2.64K | $0.00 |
| 259 | NASDAQ Bio Index SWAP BNP Paribas | — | 0.00% | 4.77K | $0.00 |
Haz clic en un ticker para ver todos los ETFs que lo incluyen.
Exposición sectorial
Exposición Geográfica
Ponderaciones por país según lo informado por el proveedor de datos. Las categorías desarrollado/emergente/frontera siguen la clasificación de la página de Metodología. Con cobertura cambiaria: No se indica cobertura de divisa en el nombre del fondo.
Distribuciones
| Rendimiento (TTM) | 0.26% | Pagado (últimos 12 meses) | $0.3223 |
| Frecuencia | Quarterly | Rendimiento SEC | No proporcionado por nuestra fuente de datos — consulte la página del emisor |
| Última fecha ex-dividendo | Mar 25, 2026 | Último pago | $0.0071 (Mar 31, 2026) |
| Crecimiento 1A | -62.12% | Crecimiento 3A / 5A (anual.) | +153.22% / — |
| Fecha ex-dividendo | Registro | Fecha de pago | Importe |
|---|---|---|---|
| Mar 25, 2026 | Mar 25, 2026 | Mar 31, 2026 | $0.0071 |
| Dec 24, 2025 | Dec 24, 2025 | Dec 31, 2025 | $0.1346 |
| Sep 24, 2025 | Sep 24, 2025 | Sep 30, 2025 | $0.1805 |
| Jun 25, 2025 | Jun 25, 2025 | Jul 01, 2025 | $0.1706 |
| Mar 26, 2025 | Mar 26, 2025 | Apr 01, 2025 | $0.1309 |
| Dec 23, 2024 | Dec 23, 2024 | Dec 31, 2024 | $0.3964 |
| Sep 25, 2024 | Sep 25, 2024 | Oct 02, 2024 | $0.1529 |
| Jun 26, 2024 | Jun 26, 2024 | Jul 03, 2024 | $0.2648 |
| Mar 20, 2024 | Mar 21, 2024 | Mar 27, 2024 | $0.0403 |
| Dec 20, 2023 | Dec 21, 2023 | Dec 28, 2023 | $0.0384 |
| Dec 22, 2022 | Dec 23, 2022 | Dec 30, 2022 | $0.0199 |
| Sep 21, 2010 | Sep 23, 2010 | Sep 28, 2010 | $0.0878 |
Rentabilidad por distribución acumulada = últimos 12 meses de efectivo distribuido ÷ precio actual. NO es la rentabilidad SEC a 30 días y no se garantiza la continuidad de las distribuciones. La diferencia explicada →
Estadísticas de riesgo
| Volatilidad 1A / 3A | 42.65% / 41.34% | Sharpe 1A / 3A | 3.31 / 1.05 |
| Máxima caída 1A / 3A | -16.92% / -45.31% | Sortino 1A | 5.43 |
| Beta vs. S&P 500 (3A) | 1.50 | Correlación con el S&P 500 (1 año) | 0.406 |
| Desviación a la baja 1A | 25.96% | Tasa libre de riesgo utilizada | 3.71% (3M T-bill, FRED) |
Calculado por ETF Explorer calculado a partir de cierres diarios ajustados por dividendos; la volatilidad y el drawdown son cifras anualizadas/del período; la exposición al S&P 500 se aproxima mediante SPY. A fecha de Aug 27, 2026. Fórmulas →
Liquidez
| Volumen hoy | 3.90K | Volumen promedio | 11.43K |
| AUM | $107.7M | Prima/Descuento | +0.13% |
| Diferencial bid/ask | No proporcionado por nuestra fuente de datos. Consulte la pantalla de cotizaciones de su bróker; los spreads son más amplios en la apertura y el cierre. | ||
La prima/descuento compara el precio de mercado diferido con el último NAV publicado — es un dato indicativo, no la prima/descuento oficial de cierre. Cómo funciona la liquidez de los ETFs →
Flujos de Fondos (estimados)
| Período | Flujo neto estimado | % del AUM inicial | AUM inicio → fin |
|---|---|---|---|
| 1 día | $5.0M | +4.89% | $102.7M → $107.7M |
| 1 semana | -$2.8M | -2.65% | $106.0M → $107.7M |
Estimación de ETF Explorer: variación en el AUM reportado menos el efecto del movimiento de mercado, calculada a partir de nuestras propias instantáneas diarias. No son datos oficiales de creaciones/reembolsos de la gestora.
Recursos oficiales del fondo
Página oficial del fondo ↗
Sitio web de la gestora del ETF (ProShares) ↗
Presentaciones ante la SEC (SEC EDGAR) ↗
Informes anuales / semestrales (SEC EDGAR) ↗
Todos los registros en la SEC ↗
Los enlaces externos abren el sitio de la gestora o SEC EDGAR en una nueva pestaña. El folleto y los documentos oficiales son siempre la fuente autorizada — consúltalos antes de invertir.
Últimas noticias de BIB
Ningún artículo menciona este fondo directamente en los últimos 7 días — mostrando cobertura general de ETF.
AI Theme Still Running Hot as Nvidia Beats Q2 Earnings Estimates ↗
Heading into Q2 fiscal 2027 earnings, the capital markets wondered if the vaunted chipmaking giant Nvidia still has its mojo. Despite rallying to…
ETF Trends · Aug 27, 11:30 UTC
Crypto ETFs: Bitcoin Leads a Broader Rebound ↗
Bitcoin has rebounded sharply from the low-$60,000s to around $80,000, gaining nearly 20% last week in one of its strongest weekly moves in years.…
ETF Trends · Aug 27, 07:06 UTC
4 High-Yield Dividend ETFs Built for a Roth IRA ↗
Covered-call and options-income ETFs solve one problem (yield) and create another (taxes).
24/7 Wall Street · Aug 27, 07:01 UTC
US weighs a new round of tariffs on semiconductors, Politico reports ↗
The Trump administration is considering a new round of sweeping tariffs on semiconductors, Politico reported on Thursday citing eight people…
Reuters · Aug 27, 05:28 UTC
Are We Misreading The Oil Demand Shock From Hormuz? ↗
Shortly after the US and Israeli strikes on Iran, a consensus formed: It was widely thought that, after a short war and a sharp spike, the cost of a…
Forbes · Aug 27, 05:25 UTC
How $500,000 in These 2 ETFs Pays $16,560 a Year With a Built-In Inflation Hedge ↗
Most investors reach for TIPS or commodities when inflation starts eroding their savings, but two overlooked asset classes have quietly outpaced…
24/7 Wall Street · Aug 27, 05:21 UTC
Todas las noticias de BIB →
Ayuda guiada: el AUM es el tamaño del fondo. El expense ratio es el coste anual que ya está descontado de los rendimientos. El NAV es el valor de lo que posee el fondo por acción; el precio de mercado puede situarse ligeramente por encima (prima) o por debajo (descuento) de este. El rendimiento total asume que las distribuciones fueron reinvertidas. Cada conjunto de datos muestra su propia fecha de referencia, ya que las posiciones, los activos y las cotizaciones se actualizan en calendarios distintos.